95 Preclinical evaluation of two human anti-HBV monoclonal antibodies in two animal models for HBV infection : E. Ilan 1, R. Eren 1, O. Nussbaum 1, I. Lubin 1, D. Terkieltaub 1, O. BenMoshe 1, Y. Arazi 1, S. Berr 1, J. Gopher J 1, A. Kitchinzky 1, D. Shouval 2, E. Galun 2, Y. Reisner 3 and S. Dagan 1. XTL Biopharmaceuticals, Kiryat Weizmann, Rehovot 1, Hadassah University Hospital, Jerusalem 2 and the Weizmann Institute of Science 3, Rehovot, ISRAEL

Zdroj: In Antiviral Research 2000 46(1):A63-A63
Databáze: ScienceDirect
Externí odkaz: